Clinical trial
Serum LncRNAs as Early Potential Biomarkers for the Prediction of Preeclampsia
NCT03903393 is registered in ClinicalTrials.gov with First Affiliated Hospital of Harbin Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Serum LncRNAs as Early Potential Biomarkers for the Prediction of Preeclampsia
- Lead sponsor
- First Affiliated Hospital of Harbin Medical University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 31, 2019
- Completion date
- March 31, 2021
- Enrollment
- 260 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
preeclampsia